WO2023024495A1 - Biocapteur et procédé de préparation associé - Google Patents

Biocapteur et procédé de préparation associé Download PDF

Info

Publication number
WO2023024495A1
WO2023024495A1 PCT/CN2022/081736 CN2022081736W WO2023024495A1 WO 2023024495 A1 WO2023024495 A1 WO 2023024495A1 CN 2022081736 W CN2022081736 W CN 2022081736W WO 2023024495 A1 WO2023024495 A1 WO 2023024495A1
Authority
WO
WIPO (PCT)
Prior art keywords
film layer
layer
conductive layer
biosensor
reaction
Prior art date
Application number
PCT/CN2022/081736
Other languages
English (en)
Chinese (zh)
Inventor
陈勋
叶小辰
胡云勇
朴瑞宁
裘丹
Original Assignee
上海微创生命科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 上海微创生命科技有限公司 filed Critical 上海微创生命科技有限公司
Publication of WO2023024495A1 publication Critical patent/WO2023024495A1/fr

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3272—Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels

Definitions

  • the invention relates to the technical field of medical devices, in particular to a biosensor and a preparation method thereof.
  • biosensor a device that uses immobilized biomolecular binding transducers to detect environmental chemicals inside or outside the organism or interact specifically with them to generate a response.
  • biosensors can be divided into tissue sensors, cell sensors, enzyme sensors, etc. , insulin sensors, etc., and biosensors can also be divided into immune sensors, drug sensors, etc. according to their uses.
  • the most commercially successful biosensor is the glucose sensor, which is used to monitor glucose in body fluids such as human blood, interstitial fluid, and sweat. Due to the huge population of diabetic patients worldwide, glucose sensors have a huge market share.
  • Glucose monitoring requires the use of a dedicated glucose detector, the core component of which is the glucose sensor.
  • Glucose sensors can be divided into in vitro sensors, fully implanted sensors and subcutaneously implanted sensors.
  • the in vitro sensor monitors the blood glucose data of a single point through fingertip blood collection.
  • the fully implanted sensor has biocompatibility problems, and the surgical implantation and removal are more complicated.
  • the subcutaneous implanted sensor is quickly implanted in a minimally invasive way. In or out, also capable of continuous glucose monitoring.
  • the subcutaneous implantable glucose sensor in the prior art has problems such as complex preparation process, high cost, short life, poor anti-interference ability, and sensitivity attenuation.
  • the object of the present invention is to provide a biosensor and a preparation method thereof, the biosensor has a simple structure and is convenient to prepare.
  • the invention provides a biosensor, comprising:
  • the electrode structure includes a substrate, a first conductive layer, a first insulating layer, a second conductive layer, a third conductive layer and a second insulating layer; wherein, the first conductive layer is formed on the substrate; the first An insulating layer is formed on the first conductive layer, and a part of the first conductive layer is exposed to form a working electrode; the second conductive layer is formed on the first insulating layer; the third conductive layer A layer is formed on a partial area of the second conductive layer; the second insulating layer is formed at least on the second conductive layer, and a partial area of the second conductive layer is exposed to form a counter electrode, and the At least a portion of the third conductive layer is exposed to form a reference electrode; and,
  • the reaction film layer is formed on the working electrode and is used for electrochemical reaction with the target.
  • the reaction film layer is formed by coating and curing a reaction reagent on the working electrode;
  • the reaction reagent includes a metal complex, a biological reaction enzyme, a polypeptide macromolecule and a first cross-linking agent.
  • the metal complexes include transition metal complexes.
  • the biological reaction enzyme includes any one of glucose oxidase, lactate oxidase, L-glutamic acid oxidase or xanthine oxidase.
  • the reaction reagent also includes a stabilizer, based on the total amount of the metal complex, biological reaction enzyme, polypeptide macromolecule, stabilizer and first crosslinking agent as 100%, the mass of the metal complex The percentage is 5% to 50%, the mass percentage of the stabilizer is 1% to 20%, the mass percentage of the polypeptide macromolecule is 1% to 20%, and the mass percentage of the first crosslinking agent is 0.1% ⁇ 10%, and the balance is the biological reaction enzyme.
  • the stabilizer includes a polymer prepolymerization solution.
  • the biosensor also includes a functional film layer; the functional film layer includes an anti-interference film layer, and the anti-interference film layer is at least arranged on the reaction film layer, the counter electrode and the reference electrode and used to prevent interfering substances from passing through the functional film layer.
  • the anti-interference film layer includes at least one of naphthol, cellulose acetate, polylysine, polyvinylpyridine and its modified copolymer, and polyurethane.
  • the functional film layer further includes an adjustment film layer, the adjustment film layer is disposed on the anti-interference film layer, and is used to regulate the passing rate of the target object on the functional film layer.
  • the regulating film layer includes a hydrophilic polymer, a hydrophobic polymer and a second crosslinking agent.
  • the adjustment film layer includes a first adjustment film layer and a second adjustment film layer, the first adjustment film layer is formed on the anti-interference film layer, and the second adjustment film layer is formed on the On the first adjustment film layer; the content of the hydrophobic polymer in the first adjustment film layer is greater than the content of the hydrophobic polymer in the second adjustment film layer.
  • the weight ratio of the hydrophilic polymer to the hydrophobic polymer is 1:9 to 1:1.1, and in the second regulating film layer, The weight ratio of the hydrophilic polymer to the hydrophobic polymer is 9:1 ⁇ 1:1.
  • the hydrophilic polymer includes polyethylene glycol, polyhydroxyethyl methacrylate, polyacrylic acid, polypropylene alcohol, chitosan, hydrophilic cellulose, and hydrophilic modified silane condensation polymers , Hydrophilic modified polyurethane, polyDMAEMA, polyNIPAM, polymethacrylamide, polydopamine, alginic acid, hyaluronic acid, sodium polystyrene sulfonate, polyethylene glycol modified vinylpyridine, polysulfonate At least one of acid-modified vinylpyridine and polycarboxy-modified 4-vinylpyrrolidone; the hydrophobic polymer includes polystyrene, polymethyl methacrylate, polyvinylpyridine, polyvinylpyrrolidone , polysilanes, polyurethanes, and polycarbonates; and/or,
  • the molecular weight distribution of the hydrophilic polymer and the hydrophobic polymer is 10000Da-1000000Da.
  • the biosensor includes an implant part, the implant part is used to implant a target object, and the working electrode, the counter electrode, the reference electrode, and the reaction film layer are all located on On the implanted part; the biosensor also includes a biocompatible layer, the biocompatible layer is located at the implanted part, and the biocompatible layer is used to cover the functional film layer together the surface of the implant.
  • the present invention also provides a method for preparing a biosensor, which is used to prepare the biosensor as described in any one of the preceding items, and the preparation method includes the following steps:
  • the reaction film layer is formed on the working electrode.
  • reaction film layer is formed on the working electrode by dispensing or inkjet process.
  • a functional film layer is formed on the reaction film layer, the counter electrode and the reference electrode.
  • the biosensor includes an implant, and the working electrode, the counter electrode, the reference electrode, and the reaction film layer are located on the implant, and the preparation method further includes : the biosensor includes an implant, the working electrode, the counter electrode, the reference electrode, and the reaction film layer are located on the implant, and the preparation method further includes: A biocompatible layer is formed on the implanted part, and the biocompatible layer is used to cover the surface of the implanted part together with the functional film layer.
  • the biosensor of the present invention Compared with the prior art, the biosensor of the present invention and its preparation method have the following advantages:
  • the aforementioned biosensor comprises a substrate, an electrode structure and a reaction membrane layer;
  • the electrode structure comprises a first conductive layer, a first insulating layer, a second conductive layer, a third conductive layer and a second insulating layer, and the first conductive layer formed on the substrate, the first insulating layer is formed on the first conductive layer, and a part of the first conductive layer is exposed to form a working electrode, and the second conductive layer is formed on the a first insulating layer, the third conductive layer is formed on a partial area of the second conductive layer, the second insulating layer is formed at least on the second conductive layer, and makes the second conductive layer A part of the area is exposed to form a counter electrode, and at least a part of the third conductive layer is exposed to form a reference electrode;
  • the reaction film layer is formed on the working electrode and is used to electrochemically react with the target,
  • the target object is, for example, any one of glucose, lactic acid, xanthine,
  • the reaction membrane layer includes metal complexes, bioreaction enzymes, polypeptide macromolecules, and a first crosslinking agent, wherein groups such as amino groups, carboxyl groups, and hydroxyl groups on the polypeptide macromolecules can be combined with the metal complexes and the first cross-linking agent.
  • the bioreaction enzyme reaction forms a covalent bond, and the core-shell structure is formed by the action of the stabilizer, which can improve the stability and lifespan of the biosensor.
  • the biosensor also includes a functional film layer
  • the functional film layer may include an anti-interference film layer and an adjustment film layer
  • the anti-interference film layer is used to prevent interfering substances from passing through the functional film layer, reducing the impact on The detection interference of the target object
  • the adjustment film layer is used to adjust the pass rate of the target object on the functional film layer, and then adjust the amount of the target object entering the reaction film layer, and improve the biosensor sensitivity.
  • Fig. 1 is a schematic diagram of the overall structure of a biosensor provided by the present invention according to an embodiment
  • Fig. 2 is a cross-sectional view of a biosensor provided by the present invention according to an embodiment
  • Fig. 3 is a schematic diagram of the core-shell structure in the reaction membrane layer of the biosensor according to an embodiment of the present invention
  • Fig. 4 is a flow chart of the preparation of the biosensor provided by the present invention according to an embodiment
  • Fig. 5 is a flow chart of the preparation of the electrode structure of the biosensor according to an embodiment of the present invention.
  • Figure 6a to Figure 6f show a schematic diagram of the preparation process of the electrode structure of the biosensor
  • Fig. 7 is a graph of response current curves of the biosensor provided by an embodiment of the present invention to different concentrations of glucose;
  • Fig. 8 is a graph showing the linear relationship between the response current and the glucose concentration of the biosensor provided by an embodiment of the present invention.
  • 1100-electrode structure 1101-implantation part, 1110-base, 1111-bonding area, 1112-electrode area, 1111a-first pin, 1111b-second pin, 1111c-third pin, 1120-first Conductive layer, 1121-first part, 1121a-first end, 1121b-second end, 1122-second part, 1123-third part, 1130-first insulating layer, 1140-second conductive layer, 1141-fourth part, 1141a-third terminal, 1141b-fourth terminal, 1142-fifth part, 1142a-fifth terminal, 1142b-sixth terminal, 1143-sixth part, 1150-third conductive layer, 1160-second insulation layer, 1001-working electrode, 1002-counter electrode, 1003-reference electrode;
  • each embodiment of the content described below has one or more technical features respectively, but this does not mean that the inventor must implement all the technical features in any embodiment at the same time, or can only implement different embodiments separately. Some or all of the technical features. In other words, on the premise that the implementation is possible, those skilled in the art can selectively implement some or all of the technical features in any embodiment according to the disclosure of the present invention and depending on design specifications or implementation requirements, or Selectively implement a combination of some or all of the technical features in multiple embodiments, thereby increasing the flexibility of the implementation of the present invention.
  • the singular forms “a”, “an” and “the” include plural objects, and the plural form “a plurality” includes two or more objects, unless the content clearly states otherwise.
  • the term “or” is generally used in the sense including “and/or”, unless the content clearly indicates otherwise, and the terms “install”, “connect” and “connect” should be To understand it in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection. It can be a mechanical connection or an electrical connection. It can be directly connected or indirectly connected through an intermediary, and it can be the internal communication of two elements or the interaction relationship between two elements. Those of ordinary skill in the art can understand the specific meanings of the above terms in the present invention according to specific situations.
  • FIG. 1 shows a schematic diagram of the overall structure of a biosensor provided by an embodiment of the present invention
  • FIG. 2 is a cross-sectional view of the biosensor.
  • the biosensor includes an electrode structure 1100 and a reaction membrane layer 1200 .
  • the electrode structure 1100 includes a substrate 1110 , a first conductive layer 1120 , a first insulating layer 1130 , a second conductive layer 1140 , a third conductive layer 1150 and a second insulating layer 1160 .
  • the first conductive layer 1120 is formed on the substrate 1100 .
  • the first insulating layer 1130 is formed on the first conductive layer 1120 and exposes a part of the first conductive layer 1120 to form the working electrode 1001 .
  • the second conductive layer 1140 is formed on the first insulating layer 1130 , and the third conductive layer 1150 is formed on a partial area of the second conductive layer.
  • the second insulating layer 1160 is formed at least on the second conductive layer 1140, and exposes a part of the second conductive layer 1140 to form the counter electrode 1002, and at least a part of the third conductive layer 1150 exposed to form a reference electrode 1003.
  • the reaction film layer 1200 is formed on the working electrode 1001 and used for electrochemical reaction with the target.
  • the "bare” means not covered, that is, the area where the working electrode 1001 is formed on the first conductive layer 1120 is not covered by the first insulating layer 1130, and the second conductive layer
  • the area where the counter electrode 1002 is formed on 1140 is not covered by the third conductive layer 1150 and the second insulating layer 1160, and the area where the reference electrode 1003 is formed on the third conductive layer 1150 is not covered by the third conductive layer 1150.
  • Covered by the second insulating layer 1160 in this embodiment, preferably, the third conductive layer 1150 is completely exposed to the second insulating layer 1160 and forms the reference electrode 1003 .
  • At least a part of the structure of the biosensor can be used to implant a target object, and the target object can be subcutaneous of a patient.
  • the part of the biosensor used to implant subcutaneous of a patient is referred to as an implant part 1101 herein, specifically as For the part shown in FIG. 1 , those skilled in the art should understand that the implanted part 1101 is the end of the electrode region 1112 as shown in FIG. The end of the electrode region 1112 away from the junction region 1111 (as described later, see the part shown in FIG. 6a ), the implanted part 1101 includes the part where the electrode structure is arranged in this position region and the reaction film layer 1200 .
  • the working electrode 1001 , the counter electrode 1002 , the reference electrode 1003 , and the reaction film layer 1200 are all located on the implanted portion 1101 .
  • the surface of the implanted part 1101 has the reaction film layer 1200, the counter electrode 1002, the reference electrode 1003, and the second electrode for separating the counter electrode 1002 and the reference electrode 1003.
  • the second insulating layer 1160 and/or the first insulating layer 1130 include the base 1110 on other parts of the surface of the implanted portion 1101 . In this way, when the implant part 1101 is implanted under the patient's skin, the biosensor can monitor the concentration of the target substance in the body fluid, such as glucose, lactose, L-glutamic acid, or xanthine.
  • the first conductive layer 1120 , the second conductive layer 1140 and the third conductive layer 1150 are all thin-layer structures, which can be shaped by coating a paste containing conductive substances on corresponding positions and curing.
  • the reaction film layer 1200 can also be formed by coating the coating containing the reactive substance on the outer surface of the working electrode 1001 and curing it.
  • the preparation process of the biosensor is simple, and the size of each electrode can be guaranteed to avoid reducing the working area of the electrode due to deviations in subsequent processes, and each film layer can have a smaller thickness, thereby reducing the size of the biosensor This will reduce the foreign body sensation when the partial structure of the biosensor is implanted under the patient's skin.
  • the arrangement of the electrode structure also improves the performance structure and performance consistency of the biosensor when the biosensor is mass-produced.
  • the substrate 1110 is made of a flexible material such as PET film, PI film, PE film or PP film, and its thickness is preferably 50um to 150um, so as to further reduce the foreign body sensation brought by the biosensor implanted subcutaneously.
  • the substrate 1110 may be in a “convex” structure, including a substantially rectangular bonding region 1111 and an elongated electrode region 1112 .
  • the bonding area 1111 is provided with a first pin 1111a electrically connected to the working electrode 1001, a second pin 1111b electrically connected to the counter electrode 1002, and a second pin 1111b electrically connected to the reference electrode 1003.
  • the connected third pin 1111c the formation of each pin will be described in detail below.
  • At least a part of the electrode area 1112 is located on the implanted part 1101 of the electrode structure 1100, that is, the working electrode 1001, the counter electrode 1002 and the reference electrode 1003 are arranged on the electrode area 1112 .
  • the first conductive layer 1120 is formed by coating a conductive paste on the substrate 1110 according to a predetermined shape by any suitable process such as screen printing, inkjet printing, laser etching, and curing.
  • the conductive paste includes at least one of carbon paste, gold paste and platinum black (ie very fine platinum powder).
  • platinum black ie very fine platinum powder
  • the first conductive layer 1120 includes a first part 1121, a second part 1122 and a third part 1123 separated from each other, wherein the first part 1121 is separated from the electrode region
  • the free end of 1112 extends to the bonding region 1111, and has an opposite first end 1121a and a second end 1121b, and the first end 1121a is located at
  • the working electrode 1001 is formed on the electrode region 1112 .
  • the second end 1121b is located on the bonding area 1111 and is used to form the first pin 1111a.
  • a region of the first portion 1121 between the first end 1121 a and the second end 1121 b constitutes a wire of the working electrode 1001 .
  • the second portion 1122 is used to form the second pin 1111b.
  • the third portion 1123 is used to form the third pin 1111c.
  • the purpose of setting the second part 1122 and the third part 1123 is to raise the lead area, so as to facilitate subsequent coating of the second conductive layer 1140 on the lead area.
  • a first insulating layer 1130 is disposed on the first conductive layer 1120 , and the embodiment of the present invention has no special limitation on the specific material and forming method of the first insulating layer 1130 .
  • the first insulating layer 1130 covers the area where the first conductive layer 1120 is not provided on the substrate 1110, and the area covering the first portion 1121 of the first conductive layer 1120 located on the The area between the first end 1121a and the second end 1121b (that is, the wire portion of the working electrode 1001 ).
  • the second conductive layer 1140 is formed.
  • the second conductive layer 1140 is coated on the first insulating layer 1130 and the first part 1121 of the first conductive layer 1120 in a predetermined shape by using conductive paste through screen printing or any other suitable process.
  • the conductive paste includes carbon paste.
  • the second conductive layer 1140 includes a fourth portion 1141 , a fifth portion 1142 and a sixth portion 1143 separated from each other.
  • both the fourth portion 1141 and the fifth portion 1142 extend from the electrode region 1112 to the bonding region 1111, and the fourth portion 1141 has a third end 1141a and a fourth end 1141b opposite to each other,
  • the third end 1141 a is located on the electrode region 1112
  • the fourth end 1141 b covers the second portion 1122 of the first conductive layer 1120 .
  • the fifth part 1142 has opposite fifth end 1142a and sixth end 1142b, the fifth end 1142a is located on the electrode region 1112, and the sixth end 1142b covers the first conductive layer 1120. on the third part 1123 described above.
  • the sixth portion 1143 covers the second end 1121b of the first portion 1121 of the first conductive layer 1120 .
  • forming the second conductive layer 1140 may be through the process of screen printing as described above, or the fourth part 1141 and the fifth part 1141 may be integrally printed or coated first. part 1142, and then remove part of the second conductive layer 1140 between the fourth part 1141 and the fifth part 1142 to complete the second conductive layer separated by the third end 1141a and the fifth end 1142a Part 1140 is used as two wires respectively connected to the fourth end 1141b and the sixth end 1142b.
  • the third conductive layer 1150 is formed on the fifth end 1142a of the fifth portion 1142 of the second conductive layer 1140 as the reference electrode 1003, also That is, the third conductive layer 1150 is connected to the fifth portion 1142 of the second conductive layer 1140 . Not only that, the third conductive layer 1150 is also separated from the fourth portion 1141 of the second conductive layer 1140 .
  • the third conductive layer 1150 is formed by screen printing process of conductive paste.
  • the conductive paste includes silver silver chloride.
  • the second insulating layer 1160 is formed, and a part of the second conductive layer 1140 is covered by the second insulating layer 1160, wherein the fourth part 1141 is located in the The region on the electrode region 1112 and close to the third conductive layer 1150 (including the third end 1141a not connected to the third conductive layer 1150, and the fifth end 1142a connected to the third conductive layer 1150) , the fourth end 1141b of the fourth portion 1141 , the sixth end 1142b of the fifth portion 1142 , and the sixth portion 1143 are not covered by the second insulating layer 1160 .
  • the area of the fifth portion 1142 close to the third conductive layer 1150 can also be covered by the second insulating layer 1160 (that is, the fifth end 1142a connected to the third conductive layer 1150 can also be covered by the second insulating layer 1160). layer 1160 coverage).
  • the exposed area of the fourth part 1141 located on the electrode region 1112 forms the counter electrode 1002 (so that the counter electrode 1002 is isolated from the reference electrode 1003)
  • the fourth part The fourth end 1141b of the first conductive layer 1141 and the second portion 1122 of the first conductive layer 1120 jointly form the second pin 1111b
  • the sixth end 1142b of the fifth portion 1142 forms the second pin 1111b together with the first
  • the third portion 1123 of a conductive layer 1120 jointly forms the third pin 1111c
  • the sixth portion 1143 and the second end 1121b of the first portion 1121 of the first conductive layer 1120 jointly form the first pin 1111a. That is to say, each pin has a two-layer structure, and the advantage of this arrangement is that the printing effect of the second conductive layer 1140 is better, and each film layer of the biosensor is more uniform.
  • the third conductive layer 1150 is formed on the fifth end 1142a of the fifth portion 1142 of the second conductive layer 1140, the fifth end 1142a of the fifth portion 1142, and the fifth end 1142a of the fifth portion 1142, and the first The part between the fifth end 1142a and the sixth end 1142b is also used as the wire of the reference electrode 1003, that is, the wire of the reference electrode 1003 is located on the same plane as the counter electrode 1002 and formed at the same time, so Doing is beneficial to maintain the consistency of the reference electrode 1003, and can simplify the production process and reduce the cost.
  • the reaction film layer 1200 can be formed by coating the outer surface of the working electrode 1001 with a reaction reagent and curing it.
  • the reaction reagent is coated on the working electrode 1001 by dispensing or inkjet process, which is beneficial to ensure the accuracy of the dosage of the reaction reagent and improve the consistency of mass production of the biosensor.
  • the reaction reagents include biological reaction enzymes, metal complexes, polypeptide macromolecules, stabilizers and first cross-linking agents. Among them, amino groups, carboxyl groups, hydroxyl groups and other groups on the polypeptide macromolecules can react with metal complexes and biological oxidases to form covalent bonds, and undergo free radical polymerization under the action of the first cross-linking agent to form
  • the shown core-shell structure improves the stability of the reaction membrane layer 1200 and prolongs the life of the biosensor. Active groups capable of reacting with the target exist on the core-shell structure.
  • the stabilizer can stabilize the performance of the reaction reagent.
  • the specific type of the biological reaction enzyme is determined according to the target.
  • the target substance is glucose
  • the bioreaction enzyme is glucose oxidase.
  • the target object is lactic acid
  • the biological reaction enzyme is lactate oxidase.
  • the target object is L-glutamic acid
  • the biological reaction enzyme is L-glutamic acid oxidase.
  • the target object is xanthine
  • the biological reaction enzyme is xanthine oxidase.
  • the metal complex may be a transition metal complex, including but not limited to at least one of an osmium (Os) complex, a rhodium (Rh) complex, and a cobalt (Co) complex.
  • Ligands can be high-molecular ligands or small-molecule ligands.
  • Optional polymer ligands include but not limited to polymethacrylates, polyacrylamides, polyvinylpyrrolidones and other long-chain branched structures; optional small molecule ligands include but not limited to nitrogen-containing heterocyclic small Molecules such as pyridine, imidazole, etc.
  • Appropriate ligands can reduce the oxidation-reduction potential of the metal, thereby reducing the operating voltage for the biological reaction enzyme to recognize and oxidize the target, and improve the reaction sensitivity of the biosensor.
  • a suitable ligand can also reduce the interference of some electroactive substances on the response current of the target under high working voltage, and improve the detection accuracy of the biosensor.
  • the polypeptide macromolecules include but are not limited to at least one of bovine serum albumin, human serum albumin, and citrulline.
  • the first crosslinking agent can be a multifunctional small molecule compound, including but not limited to a small molecule compound including a diisocyanate group and a polyisocyanate group, or at least one of a small molecule compound including a diepoxide group and a polyepoxy group. kind.
  • the stabilizer is a polymer prepolymer solution, including but not limited to polyacrylamide prepolymer solution, polyacrylate prepolymer solution, polyhydroxyethyl methacrylate prepolymer solution, poly NIPAM prepolymer solution, polyDMAEMA prepolymer solution at least one of polysolutions.
  • the total amount of the metal complex, the biological reaction enzyme, the stabilizer, the polypeptide macromolecule, and the first cross-linking agent is 100%.
  • the mass fraction of the metal complex is 5% to 50%
  • the mass fraction of the stabilizer is 1% to 20%
  • the mass fraction of the polypeptide macromolecule is 1% to 20%
  • the first The mass fraction of the cross-linking agent is 0.1%-10%
  • the balance is the biological reaction enzyme.
  • the biosensor also includes a functional film layer 1300
  • the functional film layer 1300 means a film layer that promotes the electrochemical reaction of the reaction film layer 1200
  • the functional film layer 1300 covers at least the reaction film layer 1200 , the counter electrode 1002 and the reference electrode 1003 for further improving the reaction sensitivity of the biosensor.
  • the functional film layer 1300 also covers the exposed area of the fifth portion 1142 of the second conductive layer 1140 in the electrode region 1112 .
  • the functional film layer 1300 may include an anti-interference film layer 1310, and the anti-interference film layer 1310 is used to prevent interfering substances from passing through the functional film layer 1300, so as to reduce the impact of the interfering substances on the working electrode 1001. Produce adverse effects and reduce the monitoring accuracy of biosensors.
  • the interfering substances mentioned here include at least one of acetaminophen, vitamin C, ascorbic acid and the like that may exist in body fluids.
  • the anti-interference film layer 1310 covers at least the working electrode 1001, and the anti-interference film layer 1310 is coated on the outer surface of the reaction film layer 1200 by dipping, spraying or any other suitable method and Curing and forming.
  • the anti-interference film layer 1310 can also cover the counter electrode 1002 and the reference electrode 1003. At this time, the anti-interference coating is also coated on the outer surface of the counter electrode 1002 and the reference electrode 1003. The outer surface of the electrode 1003.
  • the composition of the anti-interference film layer 1310 includes at least one of naphthol, cellulose acetate, polylysine, polyvinylpyridine and its modified copolymer, and polyurethane, and the molecular weight distribution is 10000Da-1000000Da.
  • the functional film layer 1300 also includes an adjustment film layer 1320 for regulating the passing rate of the target on the functional film layer 1300 .
  • the adjustment film layer 1320 covers the reaction film layer 1200 , the counter electrode 1002 and the reference electrode 1003 . It can be understood that when the interference film layer 1310 covers the counter electrode 1002 and the reference electrode 1003 , the adjustment film layer 1320 completely covers the anti-interference film layer 1310 .
  • the adjustment film layer 1320 mainly includes a hydrophilic polymer, a hydrophobic polymer and a second cross-linking agent, and the hydrophilic polymer and the hydrophobic polymer are under the action of the second cross-linking agent A cross-linking reaction occurs to form a three-dimensional network structure.
  • the regulating film layer 1320 When the regulating film layer 1320 is in contact with body fluid, the regulating film layer 1320 swells to form a hydrogel, and the target in the body fluid passes through the pores of the three-dimensional network structure, and further passes through the anti-interference layer After 1310, it contacts with the reaction film layer 1200 and an electrochemical reaction occurs.
  • the ratio of the hydrophilic polymer to the hydrophobic polymer By adjusting the ratio of the hydrophilic polymer to the hydrophobic polymer, the density of the pores in the three-dimensional network structure and the size of the pores can be adjusted, thereby realizing the passage of the target object rate regulation.
  • the adjustment film layer 1320 includes a first adjustment film layer 1321 and a second adjustment film layer 1322, the first adjustment film layer 1321 is coated and cured on the anti-interference film layer 1310 by a first adjustment paint , the second adjusting film layer 1322 is coated and cured on the first adjusting film layer 1321 by a second adjusting paint.
  • the content of the hydrophobic polymer in the first regulating film layer 1321 is greater than the content of the hydrophobic polymer in the second regulating film layer 1322 .
  • the weight ratio of the hydrophilic polymer to the hydrophobic polymer is 1:9 to 1:1.1, and in the second adjusting layer, the The weight ratio of the hydrophilic polymer to the hydrophobic polymer is 9:1 ⁇ 1:1.
  • the first regulating film layer 1321 can have a certain mechanical strength, and it can react to the reaction film layer 1200, the counter electrode 1002, the reference electrode 1003 and the anti-interference film layer 1310 in body fluid. play a protective role.
  • the hydrophilic performance of the second regulating membrane layer 1322 is better, which improves the biocompatibility of the biosensor.
  • the hydrophilic polymer includes but not limited to polyethylene glycol, polyhydroxyethyl methacrylate, polyacrylic acid, polypropylene alcohol, chitosan, hydrophilic cellulose, hydrophilic modified Silane polycondensate, hydrophilic modified polyurethane, polyDMAEMA, polyNIPAM, polymethacrylamide, polydopamine, alginic acid, hyaluronic acid, sodium polystyrene sulfonate, polyethylene glycol modified vinyl At least one of pyridine, polysulfonic acid-modified vinylpyridine, and polycarboxy-modified 4-vinylpyrrolidone.
  • the hydrophobic polymer includes but not limited to at least one of polystyrene, polymethylmethacrylate, polyvinylpyridine, polyvinylpyrrolidone, polysilanes, polyurethane, and polycarbonate.
  • the molecular weight distributions of the hydrophilic polymer and the hydrophobic polymer are both 10000Da-1000000Da.
  • the biosensor in order to improve the biocompatibility of the biosensor described in the present application when it is applied to the human body, the biosensor further includes a biocompatible layer 1400, which is used for Coat the surface of the implant part 1101 together with the functional film layer 1300 .
  • the embodiment of the present invention also provides a preparation method of the aforementioned biosensor, as shown in Fig. 4, Fig. 5 and Fig. 6a to Fig. 6f, the preparation method includes the following steps:
  • Step S100 preparing the electrode structure 1100.
  • Step S200 forming a reaction film layer 1200 on the working electrode 1001 .
  • step S100 includes:
  • Step S110 providing the substrate 1110;
  • Step S120 forming the first conductive layer 1120 on the substrate 1110 .
  • Step S130 forming the first insulating layer 1130 on the first conductive layer 1120 , and exposing a part of the first conductive layer 1120 to serve as the working electrode 1001 .
  • Step S140 forming the second conductive layer 1140 on the first insulating layer 1130 .
  • Step S150 forming the third conductive layer 1150 on a partial area of the second conductive layer 1140 , and the third conductive layer serves as the reference electrode 1003 .
  • Step S160 forming the second insulating layer on the second conductive layer 1140, and exposing a part of the second conductive layer 1140 as the counter electrode 1002, and the counter electrode 1002 is connected with the reference electrode 1002.
  • the specific electrodes 1003 are isolated from each other.
  • the step S200 specifically includes: coating the reaction reagent on the working electrode 1001 by dispensing or inkjet process, and curing to form the reaction film layer 1200 .
  • the preparation method further includes step S300 : forming a functional film layer 1300 at least on the reaction film layer 1200 , the counter electrode 1002 and the reference electrode 1003 .
  • the step S300 specifically includes:
  • Step S310 coating an anti-interference paint on at least the reaction film layer 1200 , the counter electrode 1002 and the reference electrode 1003 , and curing to form the anti-interference film layer 1310 .
  • Step S320 coating the first adjusting paint on the anti-interference film layer 1310, and forming the first adjusting film layer 1321 after curing.
  • Step S320 coating a second adjusting paint on the first adjusting film layer 1321, and forming the second adjusting film layer 1322 after curing.
  • the preparation method further includes step S400: forming a biocompatible layer on the implant part 1101, that is, the biocompatible layer 1200 is used for
  • the functional film layer 1300 covers the surface of the implant part 1101 together.
  • the biocompatible layer 1400 can be coated with any biocompatible paint and cured.
  • the conductive paste used to form the first conductive layer includes carbon paste. And forming the first conductive layer, the second conductive layer and the third conductive layer by screen printing process.
  • the reaction reagent is drop-coated on the working electrode through a dispensing process.
  • the biological reaction enzyme is glucose oxidase.
  • the metal complex is an osmium metal complex, specifically a graft polymerized complex, and the main chain of the polymer is an acrylate copolymer, and the ligand is biimidazole.
  • the polypeptide macromolecule is human serum albumin (HSA).
  • the stabilizer is polyacrylamide prepolymerization solution.
  • the first cross-linking agent is bis-shrunk ethylene glycol ester with a molecular weight of 1000 Da.
  • the mass percentage of glucose oxidase is 37.5%
  • the mass percentage of osmium metal complex is 45%
  • the mass percentage of human serum protein is 5%
  • the mass percentage of polyacrylamide prepolymerization solution The percentage is 10%
  • the mass percentage of bis-shrunk ethylene glycol ester is 2.5%.
  • the total solid content is 10%.
  • the anti-jamming paint includes nafine, and the mass fraction of nafine in the anti-jamming paint is 5%.
  • a first adjusting paint is coated on the anti-jamming film layer by dip coating.
  • the hydrophobic polymer includes polystyrene and polyvinylpyridine
  • the hydrophilic polymer includes polycarboxy-modified vinylpyridine
  • the second crosslinking agent is bis-shrunk ethylene glycol ester.
  • the total mass fraction of the hydrophobic polymer and the hydrophilic polymer is 20%, and in percentage by weight, the hydrophobic polymer and the hydrophilic polymer
  • the ratio of polystyrene to polyvinylpyridine is 1:1.
  • the molecular weight of the bis-shrunk ethylene glycol ester is 500, and the mass fraction is 2%.
  • a second adjustment paint is coated on the first adjustment layer by means of dip coating.
  • the hydrophobic polymer of the second adjustment coating includes polysiloxane
  • the hydrophilic polymer includes polyethylene glycol modified vinylpyridine and polysulfonic acid modified vinylpyridine
  • the second The crosslinking agent is glycidyl ester.
  • the total mass fraction of the hydrophobic polymer and the hydrophilic polymer is 20%
  • the weight ratio of the hydrophobic polymer to the hydrophilic polymer is
  • the weight ratio of polyethylene glycol-modified vinylpyridine to polysulfonic acid-modified vinylpyridine is 1:2.
  • the mass fraction of glycidyl ester is 1%.
  • the biosensor provided in this embodiment is used for performance testing.
  • the test steps are as follows:
  • the biosensor was submerged in standard PBS buffer solution and soaked for 30 minutes. Those skilled in the art know how to prepare standard PBS buffer solution. The remaining measurements on the biosensor were then performed at 0V. Wait for 10 minutes to allow the biosensor to reach a constant background, then add 5mM of glucose to the tested solution every 5 minutes, so that the glucose content in the tested solution is 0mM, 5mM, 10mM, 15mM, 20mM, 25mM, 30mM , to measure the linearity of the biosensor response. The solution was equilibrated for 5 minutes after each addition of glucose, and the solution should be continuously stirred during the measurement to make the concentration of the measurement solution uniform. The test results are shown in Figure 7 and Figure 8.
  • Figure 7 shows the current curve of the biosensor's response to glucose when the glucose of different concentrations is continuously added to the test solution under the 0V potential, and the interval between two adjacent samples is 10 seconds, where the abscissa is the number of sampling points .
  • Figure 8 shows the linear relationship between the response current of the biosensor and the glucose concentration. It can be seen from Figure 7 that the oxidation peak current increases stepwise with the addition of glucose, and it can be found from the figure that the biosensor prepared by using the scheme of the present application can change accordingly at the next sampling time when the glucose solution is added, indicating that the biosensor The response time is within 10 seconds. Compared with some existing biosensors, it shortens the feedback time of sensing environmental solutions.
  • the regulating membrane layer of the present application has a good ability to regulate the diffusion of glucose, and the reaction membrane layer has a good catalytic oxidation performance on glucose, and can quickly establish a redox balance.

Abstract

La présente invention concerne un biocapteur et un procédé de préparation associé. Le biocapteur comprend : une structure d'électrode, qui comprend un substrat, une première couche conductrice, une première couche isolante, une deuxième couche conductrice, une troisième couche conductrice, et une seconde couche isolante, la première couche conductrice étant formée sur le substrat, la première couche isolante étant formée sur la première couche conductrice et amenant une partie d'une zone de la première couche conductrice à être exposée pour former une électrode de travail, la deuxième couche conductrice étant formée sur la première couche isolante, la troisième couche conductrice étant formée sur une partie d'une zone de la deuxième couche conductrice, et la seconde couche isolante étant au moins formée sur la seconde couche conductrice et amenant une partie d'une zone de la seconde couche conductrice à être exposée pour former une contre-électrode et amenant au moins une partie d'une zone de la troisième couche conductrice à être exposée pour former une électrode de référence ; et une couche de membrane de réaction, qui est formée sur l'électrode de travail et utilisée pour une réaction électrochimique avec un objet cible. Le biocapteur a une structure simple et logique, et facilite la production par lots.
PCT/CN2022/081736 2021-08-25 2022-03-18 Biocapteur et procédé de préparation associé WO2023024495A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202110984198.1A CN113567522A (zh) 2021-08-25 2021-08-25 一种生物传感器及其制备方法
CN202110984198.1 2021-08-25

Publications (1)

Publication Number Publication Date
WO2023024495A1 true WO2023024495A1 (fr) 2023-03-02

Family

ID=78172824

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/081736 WO2023024495A1 (fr) 2021-08-25 2022-03-18 Biocapteur et procédé de préparation associé

Country Status (2)

Country Link
CN (1) CN113567522A (fr)
WO (1) WO2023024495A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116087286A (zh) * 2023-03-10 2023-05-09 上海微创生命科技有限公司 生物传感器及其制备方法和应用

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113567522A (zh) * 2021-08-25 2021-10-29 上海微创生命科技有限公司 一种生物传感器及其制备方法
CN114460147A (zh) * 2022-02-11 2022-05-10 深圳市溢鑫科技研发有限公司 一种直立石墨烯电化学微电极结构
CN116687397A (zh) * 2022-07-24 2023-09-05 深圳硅基传感科技有限公司 乳酸传感器的半透膜及其制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101023343A (zh) * 2004-08-20 2007-08-22 诺和诺德公司 用于生产细小传感器的制造工艺
CN110044986A (zh) * 2017-12-29 2019-07-23 深圳硅基传感科技有限公司 葡萄糖监测探头
CN210665602U (zh) * 2019-05-03 2020-06-02 乌宁 可植入生物传感器
CN111248924A (zh) * 2019-06-24 2020-06-09 深圳硅基传感科技有限公司 葡萄糖监测探头的工作电极及其制作方法
CN112014448A (zh) * 2020-09-01 2020-12-01 深圳硅基传感科技有限公司 生物传感器及其制备方法以及生物传感器用的聚合物膜层
CN113567522A (zh) * 2021-08-25 2021-10-29 上海微创生命科技有限公司 一种生物传感器及其制备方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101023343A (zh) * 2004-08-20 2007-08-22 诺和诺德公司 用于生产细小传感器的制造工艺
CN110044986A (zh) * 2017-12-29 2019-07-23 深圳硅基传感科技有限公司 葡萄糖监测探头
CN210665602U (zh) * 2019-05-03 2020-06-02 乌宁 可植入生物传感器
CN111248924A (zh) * 2019-06-24 2020-06-09 深圳硅基传感科技有限公司 葡萄糖监测探头的工作电极及其制作方法
CN112014448A (zh) * 2020-09-01 2020-12-01 深圳硅基传感科技有限公司 生物传感器及其制备方法以及生物传感器用的聚合物膜层
CN113567522A (zh) * 2021-08-25 2021-10-29 上海微创生命科技有限公司 一种生物传感器及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116087286A (zh) * 2023-03-10 2023-05-09 上海微创生命科技有限公司 生物传感器及其制备方法和应用

Also Published As

Publication number Publication date
CN113567522A (zh) 2021-10-29

Similar Documents

Publication Publication Date Title
WO2023024495A1 (fr) Biocapteur et procédé de préparation associé
JP5595038B2 (ja) 分析物センサ装置ならびにその製造方法、組成物及びキット
JP4797024B2 (ja) 導管なし埋め込み式針状生物センサー
US8660628B2 (en) Analyte sensors comprising blended membrane compositions and methods for making and using them
US20220022786A1 (en) Polycarbonate urea/urethane polymers for use with analyte sensors
US10194840B2 (en) Microarray electrodes useful with analyte sensors and methods for making and using them
US20040108226A1 (en) Continuous glucose quantification device and method
US20120186997A1 (en) Layered enzyme compositions for use with analyte sensors
CN109312383B (zh) 用于连续葡萄糖传感器的原位化学堆栈
WO2019222499A1 (fr) Membrane de limitation de glucose thermiquement stable pour capteurs de glucose
CN216082588U (zh) 一种生物传感器
US20230346274A1 (en) Thermally stable glucose limiting membrane for glucose sensors
US20220240823A1 (en) Interference rejection membranes useful with analyte sensors
CN116649970A (zh) 对乳酸进行监测的传感器及其制备方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22859850

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE